Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
JAMA. 2021 May 4;325(17):1744-1754. doi: 10.1001/jama.2021.4172.
JAMA. 2021.
PMID: 33944876
Free PMC article.
Clinical Trial.